Hey Cindy
Thougth you'd appreciate this update: spoke with a real talker at Advanced Biotechnologies about MDI and the new JV Regenere:
1. ABT has some really hot scar reduction product called Kelo-Cote
they even have a super web site: www.KELOCOTE.com (check it out)
which is a silicon gel which when applied to an older scar will actually reduce the scar's thickness, height and overall appearance.(also they have a whole new line of "cosmecuticals" which they've been developing with {you guessed it} MLSC! one of these new products actually reduces the appearance of stretch marks and wrinkles). ABT even has patents on all of this!
2. MDI has developed some revolutionary products based on all of those patents they've been collecting over the years which are useful in skin and wound care (something to do with MDI's Japanese R&D group)
3. The new JV is called Regenere (means to revitalize-French-Kulas' wife is from Paris and worked in the cosmetics industry-) this new line of "cosmeceuticals" is based on ABT/MDI technologies and MDI/ABT clinical science...they even have a new marketing person joining them from Paris to launch Regenere's marketing/advertising campaign!
4. Regenere already has distribution contracts in place, and is signing more...targets are: plastic surgeons/hospitals/dermatologists
and Cosmetics industry: skin care/scar reduction etc.
5. The reason for all the activity is to create companies (Regenere), divisions (MDI Health care systems), strategic alliances (ABT/MDI) and other Joint Ventures which will allow MDI and ABT to maximize their technologies for the "consumer" markets, so both MDI and ABT can individually (but with some mutual collaboration) pursue FDA approvals for their "core technologies" (MLSC: HIV/AIDS drug, Blood Decontamination/Sterilization, medical/dental sterilizer, anti-bacterial agents etc; ABT: "implants")
6. Both MDI CEO (Kulas) and ABT CEO (Berlat) are friends and share same philosophies...innovation, scientific validation, strategic alliance approach to business
7. MDI brings technology, patents, world-class institutional relationships, strong R&D (USA/Japan), products...
8. ABT brings technology, patents, products, clean room manufacturing, R&D
When you add it all up seems likes Regenere should be a winner, with the biggest winners of all MLSC and ABT
Bye for now...
"Private Eyes" |
